Can-Fite BioPharma Ltd.
CANF
$3.39
$0.030.89%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.72% | -57.36% | -- | -- | -- |
| Total Depreciation and Amortization | 242.86% | 562.50% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.10% | 0.46% | -- | -- | -- |
| Change in Net Operating Assets | 262.17% | 155.09% | -- | -- | -- |
| Cash from Operations | -17.18% | -48.22% | -- | -- | -- |
| Capital Expenditure | 60.00% | 55.56% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -- | -- | -- |
| Cash from Investing | -100.13% | -100.07% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.52% | 180.22% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00% | -- | -- | -- |
| Cash from Financing | 43.70% | 193.97% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 145.45% | 139.02% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.52% | 146.76% | -- | -- | -- |